HTA 2019 in Europe - Harmonisation Ahead?
19.05.2018 06:55
The Commission's proposal for a Regulation on Health Technology Assessment (HTA) strengthened the discussion on whether and how to harmonise HTA in Europe. This conference informs you on the EU collaboration models to date, the Commission's proposal and what to expect as of 2019.
Termindetails
Wann
14.09.2018
von 09:00 bis 17:00
von 09:00 bis 17:00
Wo
Berlin
Kontakttelefon
+49 6221 500-680
Teilnehmer
This conference addresses the needs of employees in the pharmaceutical industry responsible for market access activities in the various national European markets.
Those involved in value-assessment preparation and pricing activities will benefit particularly from this conference.
Those involved in value-assessment preparation and pricing activities will benefit particularly from this conference.
The Commission's proposal for a Regulation on Health Technology Assessment (HTA) strengthened the discussion on whether and how to harmonise HTA in Europe.
This conference informs you on the EU collaboration models to date, the Commission's proposal and what to expect as of 2019.
This conference informs you on the EU collaboration models to date, the Commission's proposal and what to expect as of 2019.
Participate in this conference to learn how far we have come with regard to harmonising HTA in the EU (and beyond).
Themen des Seminars:
- European HTA and pricing collaborations to date: What has been achieved?
- Strengthening EU cooperation on HTA: The Commission's proposal
- European Early Dialogues experiences
- National HTA in England: What of EU cooperation?
- European orphan drug collaboration to date
- Strengthening EU cooperation on HTA: The Commission's proposal
- European Early Dialogues experiences
- National HTA in England: What of EU cooperation?
- European orphan drug collaboration to date
